A phase II trial of cisplatin and irinotecan alternating with doxorubicin, cyclophosphamide and etoposide in previously untreated patients with extensive-disease small-cell lung cancer
2007 ◽
Vol 60
(1)
◽
pp. 1-6
◽
Keyword(s):
Phase Ii
◽